Discovery of a Covalent Small-Molecule eEF1A1 Inhibitor via Structure-Based Virtual Screening
Journal of Chemical Information and Modeling · 2026
DOI: 10.1021/acs.jcim.5c02496 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, 2026. Verfasst von Yangping Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Nankai University, 94 Weij…. Hauptthemen laut MEDLINE: Peptide Elongation Factor 1, Small Molecule Libraries, Drug Discovery. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, People's Government of Yunnan Province, Haihe Laboratory of Sustainable Chemical Transformations.
Abstract (Originalsprache)
Pancreatic cancer remains a formidable health challenge due to its late-stage diagnosis and limited therapeutic options, underscoring the need for novel targets and modalities. Our previous work revealed that the natural product, BE-43547A2, could effectively inhibit the progression of pancreatic cancer by the covalent binding to eukaryotic translation elongation factor 1 α 1 (eEF1A1) at Cys234 (C234). Considering the critical role in protein synthesis and the association with pancreatic cancer progression, eEF1A1 is a novel promising target for pancreatic cancer. However, the rational drug design methods for eEF1A1 are extremely lacking. Herein, using microsecond-scale molecular dynamics (MD) simulations, we identify a suitable eEF1A1 conformation for structure-based virtual screening (SBVS) by targeting the residue of C234. Through a tailored SBVS pipeline, we identified AKOS-04 as a novel small-molecule covalent inhibitor with nanomolar-level potency (IC50 = 28.5 ± 2.86 nM in the PATU8988T cell line). Notably, cellular thermal shift assays (CETSA), with the treatments of dithiothreitol (DTT) and iodoacetamide (IAM), confirmed the covalent Cys-involved interaction of AKOS-04 and eEF1A1. Further structural modification validated the critical contribution of a double bond in the acrylamide group of AKOS-04 for its covalent binding with eEF1A1, manifested by the abolished inhibitory activity of compound 9 with the changed single bond in the acrylamide group. MST experiments confirmed direct binding of the compounds to eEF1A1 protein. AKOS-04 exhibited the strongest binding among the tested compounds, consistent with effective covalent target. Finally, MD simulations and pair-interaction energy analyses highlighted Lys84, Arg218, and Glu230 of eEF1A1 as key residues for driving its binding interactions to AKOS-04. These results reveal that AKOS-04, screened by SBVS against C234 of eEF1A1, represents a promising lead for eEF1A1-targeted pancreatic cancer therapy, highlighting the power of computational approaches in covalent drug discovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry, State Key Laboratory of Medicinal Chemical Biology, Frontiers Science Center for New Organic Matter, Nankai University, 94 Weijin Road, Tianjin 300071, China.
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Haihe Education Park, 38 Tongyan Road, Tianjin 300353, China.
- Biodesign Center, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, 32 West seventh Avenue, Tianjin Airport Economic Area, Tianjin 300308, China.
- Research Center for Analytical Sciences, Frontiers Science Center for New Organic Matter,College of Chemistry, Nankai University, Tianjin Key Laboratory of Biosensing and Molecular Recognition, State Key Laboratory of M…
- Haihe Laboratory of Sustainable Chemical Transformations, Tianjin 300192, China.
- Haihe Laboratory of Sustainable Chemical Transformations, 6 Keyanxi Road, Tianjin 300192, China.
ORCID-Profile: Yangping Deng, Jianping Lin, Haohao Fu, Jing Li, Yue Chen
Förderung
- Ministry of Science and Technology of the People's Republic of China
- People's Government of Yunnan Province
- Haihe Laboratory of Sustainable Chemical Transformations
- Guangzhou Laboratory
Zitieren
APA
Deng, Y., Li, S., Wang, L., Lin, J., Fu, H., Li, J., & Chen, Y. (2026). Discovery of a Covalent Small-Molecule eEF1A1 Inhibitor via Structure-Based Virtual Screening. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.5c02496
Vancouver
Deng Y, Li S, Wang L, Lin J, Fu H, Li J, et al. Discovery of a Covalent Small-Molecule eEF1A1 Inhibitor via Structure-Based Virtual Screening. Journal of Chemical Information and Modeling. 2026. doi:10.1021/acs.jcim.5c02496
BibTeX
@article{Deng2026,
author = {Deng, Yangping and Li, Sizheng and Wang, Liang and Lin, Jianping and Fu, Haohao and Li, Jing and Chen, Yue},
title = {Discovery of a Covalent Small-Molecule eEF1A1 Inhibitor via Structure-Based Virtual Screening},
journal = {Journal of Chemical Information and Modeling},
year = {2026},
doi = {10.1021/acs.jcim.5c02496}
}
EUVIMED